Minerva Neurosciences (NERV) Notes Payables (2013 - 2018)

Minerva Neurosciences (NERV) has 6 years of Notes Payables data on file, last reported at $1.4 million in Q2 2018.

• For the quarter ending Q2 2018, Notes Payables fell 72.43% year-over-year to $1.4 million; the trailing twelve-month figure through Jun 2018 stood at $1.4 million (down 72.43% YoY), and the FY2017 full-year result was $4.0 million, down 18.36% from the prior year.
• Notes Payables for Q2 2018 stood at $1.4 million, down from $2.7 million in the prior quarter.
• Across five years, Notes Payables topped out at $5.2 million in Q3 2017 and bottomed at $158263.0 in Q1 2015.
• The 5-year median for Notes Payables is $2.7 million (2018), against an average of $3.0 million.
• The widest annual swing landed in 2016, when Notes Payables jumped 1788.21%; it then tumbled 72.43% in 2018.
• A 5-year view of Notes Payables shows it stood at $2.0 million in 2014, then dropped by 28.53% to $1.4 million in 2015, then surged by 238.3% to $4.9 million in 2016, then fell by 18.36% to $4.0 million in 2017, then slumped by 64.75% to $1.4 million in 2018.
• The last three Notes Payables figures came in at $1.4 million (Q2 2018), $2.7 million (Q1 2018), and $4.0 million (Q4 2017), per Business Quant data.

Peer Comparison